Published in Cancer Res Treat on September 11, 2014
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol (2003) 12.82
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Factors influencing the natural history of colorectal liver metastases. Lancet (1994) 3.61
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg (1997) 2.36
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol (2009) 1.70
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol (2004) 1.56
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg (1997) 1.41
Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg (2005) 1.26
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg (2008) 1.18
Surgical therapy of hepatic colorectal metastasis. Semin Oncol (1999) 1.15
The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg (2004) 1.08
Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol (2009) 0.95
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Current status of surgery in colorectal metastases to the liver. Hepatogastroenterology (2001) 0.89
Accomplishments in 2008 in the management of curable metastatic colorectal cancer. Gastrointest Cancer Res (2009) 0.86
Predictive models in colorectal liver metastases--can we personalize treatment and outcome? Dig Surg (2009) 0.81
A modified grading system for post-hepatectomy metastatic liver cancer originating from colorectal carcinoma. J Surg Oncol (2008) 0.78
The impact of new technology on hepatic resection for malignancy. Arch Surg (2001) 0.77
Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol (2009) 0.98
The Clinical Features and Predictive Risk Factors for Reoperation in Patients With Perianal Crohn Diseases; A Multi-Center Study of a Korean Inflammatory Bowel Disease Study Group. Ann Coloproctol (2015) 0.96
A comprehensive review of inflammatory bowel disease focusing on surgical management. J Korean Soc Coloproctol (2012) 0.91
Clinical outcomes of metallic stent insertion for obstructive colorectal cancer. Hepatogastroenterology (2006) 0.91
Feasibility and safety of a fold-over diverting ileostomy reversal after rectal cancer surgery: case-matched comparison to the resection technique. Ann Coloproctol (2014) 0.88
Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res (2014) 0.88
18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer. J Surg Oncol (2011) 0.88
Hand-sewn coloanal anastomosis for distal rectal cancer: long-term clinical outcomes. J Gastrointest Surg (2005) 0.80
Underweight body mass index as a predictive factor for surgical site infections after laparoscopic appendectomy. Yonsei Med J (2014) 0.79
Clinical implications of microsatellite instability in T1 colorectal cancer. Yonsei Med J (2015) 0.78
Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2011) 0.78
Development of a rating system for digestive system impairments: Korean Academy of Medical Sciences Guideline. J Korean Med Sci (2009) 0.78
Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol (2012) 0.77
Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients. J Korean Soc Coloproctol (2011) 0.77
p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer. Cancer Res Treat (2015) 0.77
An extragastrointestinal stromal tumor in the omentum with peritoneal seeding mimicking an appendiceal mucinous cancer with carcinomatosis. Ann Coloproctol (2014) 0.76
T3 subdivision correlation with nodal or distant metastasis in colorectal cancer; is it practically useful? J Korean Soc Coloproctol (2012) 0.75
Robotic colorectal surgery: is it still on the way to a landmark? J Korean Soc Coloproctol (2012) 0.75
Xanthogranulomatous Appendicitis Mimicking Residual Burkitt's Lymphoma After Chemotherapy. Ann Coloproctol (2016) 0.75
Is A Mode of Presentation of Colorectal Cancer Different According to Each Individual's Social-economic Status? Ann Coloproctol (2016) 0.75
Genomic predictor of complete response after chemoradiotherapy in rectal cancer. Ann Transl Med (2016) 0.75
Paradigm Shift in the Treatment of Elderly Patients With Unresectable Stage IV Colorectal Cancer. Ann Coloproctol (2014) 0.75
Early detection of colorectal cancer, is it a guarantee for the cure of cancer? J Korean Soc Coloproctol (2012) 0.75
Metastatic cholangiocarcinoma as a cause of appendicitis: a case report and literature review. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports. Ann Coloproctol (2016) 0.75
Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy. Ann Coloproctol (2017) 0.75
Intestinal Perforation: A Surgeon's Nightmare Enlightened by Scientific Research. Ann Coloproctol (2016) 0.75
Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas. Cancer Res Treat (2015) 0.75
Clinical significance of lactate clearance for the development of early allograft dysfunction and short-term prognosis in deceased donor liver transplantation. Clin Transplant (2017) 0.75
Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer? Ann Coloproctol (2014) 0.75
Novel anal sphincter saving procedure with partial excision of levator-ani muscle in rectal cancer invading ipsilateral pelvic floor. Ann Surg Treat Res (2017) 0.75
Transanal Endoscopic Operation Versus Conventional Transanal Excision for Rectal Tumors: Case-Matched Study with Propensity Score Matching. World J Surg (2017) 0.75
Herniation after deep circumflex iliac artery flap: two cases of rare complication. Maxillofac Plast Reconstr Surg (2016) 0.75